Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine

Journal of the American Academy of Dermatology

Volumn 43, Issue 3, 2000, Pages 540-546

  Marcoux, Danielle ^a,b   Anex, Romain ^a,b   Russo, Pierre ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; FOTEMUSTINE; MITOMYCIN C; NAVELBINE; VINCRISTINE;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG ERUPTION; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; MALE; PRIORITY JOURNAL; RASH; RHABDOMYOSARCOMA; SKIN BIOPSY; VEIN BLOOD FLOW;

EID: 0033857947     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.106239     Document Type: Article

References (32)

1. Rhabdomyosarcoma and other soft tissue sarcomas in children
2. Pretreatment TNM staging of childhood rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Study Group
3. Factors that influence treatment decisions in childhood rhabdomyosarcoma
4. Paratesticular rhabdomyosarcoma
5. Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma
6. High-dose induction chemotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma
7. Cutaneous complications of chemotherapeutic agents
8. Mucocutaneous reactions to chemotherapy
9. 5-day IV infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy
10. Serpentine supravenous fluorouracil hyperpigmentation
11. Unusual pigmentary changes associated with 5-fluorouracil therapy
12. Supravenous hyperpigmentation induced by vinorelbine
13. Serpentine supravenous hyperpigmentation induced by the nitrosourea fotemustine
14. Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma
15. Chemotherapy-associated supravenous hyperpigmentation
16. Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil
17. Localized epidermal necrolysis (erythema multiforme-like reaction) following intravenous injection of vinblastine
18. Persistent supravenous erythematous eruption: A rare local complication of intravenous 5-fluorouracil therapy
19. Unusual local cutaneous reaction to dacarbazine
20. Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy
21. 'Adriamycin flare': A skin reaction resembling extravasation
22. Urticaria following intravenous doxorubicin administration
23. New histopathologic findings in drug eruptions
24. The cutaneous histopathology of chemotherapeutic reactions
25. Cutaneous eruptions of lymphocyte recovery
26. Neutrophilic eccrine hidradenitis: A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy
27. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia
28. Unusual serpentine hyperpigmentation associated with 5-fluorouracil
29. Linear hyperpigmentation overlying veins in association with collagen vascular disease
30. A new skin manifestation of progressive systemic sclerosis